CLOV icon

Clover Health Investments
CLOV

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$3.1
42% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Leerink Partners
Leerink Partners
Whit Mayo
5 Mar ‘26 1 month ago
Canaccord Genuity
Canaccord Genuity
Richard Close
33% 1-yr CLOV win rate
20 Jan ‘26 2 months ago